R Andrew Seaton (R A Seaton, Andrew Seaton)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 19

Top Venues

JAC-antimicrobial resistance

The Journal of antimicrobial chemotherapy

Expert review of anti-infective therapy

BMJ open

NHS Greater Glasgow and Clyde

This page only lists publications with an associated author ORCID identifier.

Affiliation History

NHS Greater Glasgow and Clyde Jan 05 2000

United Kingdom

Consultant Physician :: Medicine

Publications

Saiyuri Naicker, Jason Alexander Roberts, Hayoung Won, Steven C Wallis, Sean Unwin, Conor Jamieson, Tim Hills, Mark Gilchrist, Mark Santillo, R Andrew Seaton, Felicity Drummond, Fekade Bruck Sime
Evaluation of the stability of ceftazidime/avibactam in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy utilizing a national stability protocol framework. JAC-antimicrobial resistance 6 (2) (2024)
R Andrew Seaton, M Gilchrist
Making a case for outpatient parenteral antimicrobial therapy (OPAT). The Journal of antimicrobial chemotherapy 79 (8) (2024)
Hayam Al Balushi, Amanj Baker Kurdi, Najla Almutairi, Kirmanj Ismail Baker, Karwan M Amen, Hardee Karwi, R Andrew Seaton, Brian B Godman
Impact of the COVID-19 pandemic on the utilisation and quality of antibiotic use in the Scottish primary care setting: a population-based segmented interrupted time-series analysis. Expert review of anti-infective therapy (2024)
Jacqueline Sneddon, Gary John Macfarlane, Gareth T Jones, Laura Moir, Rebecca Parr, David R Jenkins, Tracey Guise, Jonathan A T Sandoe, R Andrew Seaton, null null
Introducing the UK Antimicrobial Registry (UKAR) study: providing real world data on new antimicrobials to support antimicrobial stewardship and tackle antimicrobial resistance. JAC-antimicrobial resistance 6 (4) (2024)
Saiyuri Naicker, Jason Alexander Roberts, Hayoung Won, Steven C Wallis, Sean Unwin, Conor Jamieson, Tim Hills, Mark Gilchrist, Mark Santillo, R Andrew Seaton, Felicity Drummond, Fekade Bruck Sime
Evaluation of the stability of ceftazidime/avibactam in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy utilizing a national stability protocol framework. JAC-antimicrobial resistance 6 (2) (2024)
Saiyuri Naicker, Jason Alexander Roberts, Hayoung Won, Steven C Wallis, Sean Unwin, Conor Jamieson, Tim Hills, Mark Gilchrist, Mark Santillo, R Andrew Seaton, Felicity Drummond, Fekade Bruck Sime
Evaluation of the stability of ceftazidime/avibactam in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy utilizing a national stability protocol framework. JAC-antimicrobial resistance 6 (2) (2024)
Saiyuri Naicker, Jason Alexander Roberts, Hayoung Won, Steven C Wallis, Sean Unwin, Conor Jamieson, Tim Hills, Mark Gilchrist, Mark Santillo, R Andrew Seaton, Felicity Drummond, Fekade Bruck Sime
Evaluation of the stability of ceftazidime/avibactam in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy utilizing a national stability protocol framework. JAC-antimicrobial resistance 6 (2) (2024)
Jacqueline Sneddon, Gary John Macfarlane, Gareth T Jones, Laura Moir, Rebecca Parr, David R Jenkins, Tracey Guise, Jonathan A T Sandoe, R Andrew Seaton, null null
Introducing the UK Antimicrobial Registry (UKAR) study: providing real world data on new antimicrobials to support antimicrobial stewardship and tackle antimicrobial resistance. JAC-antimicrobial resistance 6 (4) (2024)
Amanj Baker Kurdi, Najla Al Mutairi, Kirmanj Baker, Karwan M-Amen, Omeed Darweesh, Hardee Karwi, R Andrew Seaton, Jacqueline Sneddon, Brian B Godman
Impact of COVID-19 pandemic on the utilization and quality of antibiotic use in the primary care setting in England, March 2019-March 2023: a segmented interrupted time series analysis of over 53 million individuals. Expert review of anti-infective therapy (2024)
R Andrew Seaton, M Gilchrist
Making a case for outpatient parenteral antimicrobial therapy (OPAT). The Journal of antimicrobial chemotherapy (2024)
Mark Gilchrist, Conor Jamieson, Felicity Drummond, Tim Hills, R Andrew Seaton, Mark Santillo
Assessment of ceftolozane/tazobactam degradation profile and toxicity data in elastomeric devices for continuous infusion via outpatient parenteral antimicrobial therapy (OPAT). JAC-antimicrobial resistance 5 (2) (2023)
Charis A Marwick, Anower Hossain, Rita Nogueira, Jacqueline Sneddon, Kim Kavanagh, Marion Bennie, R Andrew Seaton, Bruce Guthrie, William Malcolm
Feedback of Antibiotic Prescribing in Primary Care (FAPPC) trial: results of a real-world cluster randomized controlled trial in Scotland, UK. The Journal of antimicrobial chemotherapy 77 (12) (2022)
Lesley Cooper, Nikolai Stankiewicz, Jacqueline Sneddon, R Andrew Seaton, Andrew J Smith
Indications for the use of metronidazole in the treatment of non-periodontal dental infections: a systematic review. JAC-antimicrobial resistance 4 (4) (2022)
Mark Gilchrist, David A Barr, Felicity Drummond, Alison Muir, John Williams, James Scriven, Susan Snape, Carolyn Hemsley, Chris O Durojaiye, Sanjay Patel, R Andrew Seaton
Outpatient parenteral antimicrobial therapy (OPAT) in the UK: findings from the BSAC National Outcomes Registry (2015-19). The Journal of antimicrobial chemotherapy 77 (5) (2022)
Isobel Guthrie, William Malcolm, Rita Nogueira, Jacqueline Sneddon, R Andrew Seaton, Charis A Marwick
Associations between declining antibiotic use in primary care in Scotland and hospitalization with infection and patient satisfaction: longitudinal population study. The Journal of antimicrobial chemotherapy 77 (9) (2022)
Conor Jamieson, Felicity Drummond, Tim Hills, Laima Ozolina, Mark Gilchrist, R Andrew Seaton, Mark Santillo, Alan-Shaun Wilkinson, Michael C Allwood
Assessment of ceftolozane/tazobactam stability in elastomeric devices and suitability for continuous infusion via outpatient parenteral antimicrobial therapy. JAC-antimicrobial resistance 3 (3) (2021)
Maria Dimitrova, Mark Gilchrist, R Andrew Seaton
Outpatient parenteral antimicrobial therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses. BMJ open 11 (9) (2021)
R Andrew Seaton, Lesley Cooper, Cheryl L Gibbons, William Malcolm, Brian Choo-Kang, David Griffith, Stephanie Dundas, Suzanne Brittain, Kayleigh Hamilton, Danielle Jeffreys, Rachel McKinney, Debbie Guthrie, Jacqueline Sneddon
Antibiotic prescribing for respiratory tract infection in patients with suspected and proven COVID-19: results from an antibiotic point prevalence survey in Scottish hospitals. JAC-antimicrobial resistance 3 (2) (2021)
Matthew Scarborough, Ho Kwong Li, Ines Rombach, Rhea Zambellas, Ann Sarah Walker, Martin A McNally, Bridget L Atkins, Michelle Kümin, Benjamin A Lipsky, Harriet Hughes, Deepa Bose, Simon Warren, Damien Mack, Jonathan Folb, Elinor Moore, Neil Jenkins, Susan Hopkins, R Andrew Seaton, Carolyn Hemsley, Jonathan A T Sandoe, Ila Aggarwal, Simon Ellis, Rebecca Sutherland, Claudia Geue, Nicola McMeekin, Claire Scarborough, John Paul, Graham S Cooke, Jennifer Bostock, Elham Khatamzas, Nick Wong, Andrew J Brent, Jose Lomas, Philippa Clare Matthews, Tri Wangrangsimakul, Roger Gundle, Mark Rogers, Adrian Taylor, Guy E Thwaites, Philip Bejon
Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT. Health technology assessment (Winchester, England) 23 (38) (2020)

R Andrew Seaton.css-eqlu8i{font-size:small;padding-left:4px;} (R A Seaton, Andrew Seaton)

Publication Activity (10 Years)

Top Topics

Top Venues

R Andrew Seaton (R A Seaton, Andrew Seaton)